Article Details

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Retrieved on: 2025-10-06 15:53:14

Tags for this article:

Click the tags to see associated articles and topics

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials. View article details on hiswai:

Excerpt

Monoclonal antibodies are a class of drugs that are engineered in the laboratory and mimic the function of natural antibodies made by our immune ...

Article found on: newsroom.ucla.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo